This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Psoriasis  • Dermatology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Francesca Sampogna, BD, MPH; Francesco Sera, DStat; Eva Mazzotti, DSc; Paolo Pasquini, MD, MPH; Angelo Picardi, MD; Damiano Abeni, MD, MPH; and the IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Study Group

Arch Dermatol. 2003;139:353-358.

Background  There is a need to evaluate severity of psoriasis with a simple, patient-assessed instrument.

Objective  To investigate whether the self-administered Psoriasis Area and Severity Index (SAPASI) could be used as a measure of severity in different clinical types of psoriasis.

Design  Hospital-based cross-sectional study, with measures of clinical severity collected separately by dermatologists (PASI) and patients with psoriasis (SAPASI).

Setting  Part of a large project on clinical, epidemiological, emotional, and quality-of-life aspects of psoriasis (the IDI Multipurpose Psoriasis Research on Vital Experiences study), performed between February 21 and August 31, 2000, at the inpatient wards of the Istituto Dermopatico dell'Immacolata–Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy.

Patients  The study population comprised 351 eligible patients with complete sets of information on PASI and SAPASI hospitalized at IDI-IRCCS with a diagnosis of psoriasis.

Main Outcome Measures  Correlation between PASI and SAPASI scores and analysis of variance on the difference between PASI and SAPASI scores in subsets of patients based on clinical and sociodemographic characteristics.

Results  A high correlation between the 2 measures was observed (overall Pearson correlation coefficient, r = 0.69). The SAPASI values were higher and had a wider scattering than PASI values, and SAPASI was able to discriminate properly between clinical types and global severity as assessed by dermatologists.

Conclusions  The SAPASI scoring system is well understood and accepted by patients in different populations than previously tested, adding confidence in the validity of the instrument. It could be used as a severity measure for psoriasis even for "at-distance" follow-up. Some caution, though, is needed when using SAPASI strictly to estimate PASI measurements, especially for guttate psoriasis.

From the Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata–Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy. The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stress, Social Support, Emotional Regulation, and Exacerbation of Diffuse Plaque Psoriasis
Picardi et al.
Psychosomatics 2005;46:556-564.
ABSTRACT | FULL TEXT  

Relationship Between Smoking and the Clinical Severity of Psoriasis
Fortes et al.
Arch Dermatol 2005;141:1580-1584.
ABSTRACT | FULL TEXT